A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
29 03 2021
Historique:
received: 06 12 2020
accepted: 05 03 2021
revised: 19 02 2021
entrez: 30 3 2021
pubmed: 31 3 2021
medline: 29 6 2021
Statut: epublish

Résumé

Deep brain stimulation (DBS) is a promising treatment for severe, treatment-resistant obsessive-compulsive disorder (OCD). Here, nine participants (four females, mean age 47.9 ± 10.7 years) were implanted with DBS electrodes bilaterally in the bed nucleus of the stria terminalis (BNST). Following a one-month postoperative recovery phase, participants entered a three-month randomised, double-blind, sham-controlled phase before a twelve-month period of open-label stimulation incorporating a course of cognitive behavioural therapy (CBT). The primary outcome measure was OCD symptoms as rated with the Yale-Brown Obsessive-Compulsive Scale (YBOCS). In the blinded phase, there was a significant benefit of active stimulation over sham (p = 0.025, mean difference 4.9 points). After the open phase, the mean reduction in YBOCS was 16.6 ± 1.9 points (χ

Identifiants

pubmed: 33782383
doi: 10.1038/s41398-021-01307-9
pii: 10.1038/s41398-021-01307-9
pmc: PMC8007749
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Références

Mol Psychiatry. 2010 Jan;15(1):64-79
pubmed: 18490925
Brain. 2020 May 1;143(5):1603-1612
pubmed: 32352147
Biomed Eng Online. 2018 Mar 27;17(1):37
pubmed: 29580236
Soc Psychiatry Psychiatr Epidemiol. 2002 Apr;37(4):153-63
pubmed: 12027241
Sci Data. 2019 Oct 30;6(1):244
pubmed: 31666530
Neuroimage. 2012 Apr 2;60(2):1226-35
pubmed: 22245260
J Neurosci. 2007 Apr 4;27(14):3743-52
pubmed: 17409238
Sci Data. 2018 Apr 17;5:180063
pubmed: 29664465
Cortex. 2015 May;66:60-8
pubmed: 25800506
Psychol Med. 2014 Dec;44(16):3515-22
pubmed: 25065708
Wellcome Open Res. 2019 Apr 1;4:63
pubmed: 31069261
Biol Psychiatry. 2014 Dec 15;76(12):963-9
pubmed: 24832866
Ann Clin Psychiatry. 2017 Feb;29(1):17-26
pubmed: 28207912
Am J Psychiatry. 2020 Mar 1;177(3):265-271
pubmed: 31906709
Mol Psychiatry. 2016 Sep;21(9):1272-80
pubmed: 26303665
Brain Stimul. 2020 Nov - Dec;13(6):1863-1870
pubmed: 32919091
Lancet. 1999 Oct 30;354(9189):1526
pubmed: 10551504
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
PLoS Comput Biol. 2017 Feb 23;13(2):e1005350
pubmed: 28231282
Neuroimage. 2017 Sep;158:332-345
pubmed: 28711737
Br J Psychiatry. 2008 Jan;192(1):52-8
pubmed: 18174510
Mol Psychiatry. 2021 Apr;26(4):1234-1247
pubmed: 31664175
N Engl J Med. 2013 Feb 14;368(7):610-22
pubmed: 23406026
Brain. 2018 Aug 1;141(8):2445-2456
pubmed: 29982424
Brain. 2019 Oct 1;142(10):3086-3098
pubmed: 31377766
Brain. 2016 Sep;139(Pt 9):2503-15
pubmed: 27412387
Neuroimage Clin. 2018 Mar 13;18:996-1006
pubmed: 29876284
Trends Cogn Sci. 2004 Apr;8(4):170-7
pubmed: 15050513
Biol Psychiatry. 2019 May 1;85(9):735-743
pubmed: 30777287
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Brain Stimul. 2021 Jan-Feb;14(1):1-3
pubmed: 33130018
Brain Struct Funct. 2014 Sep;219(5):1801-12
pubmed: 23797209
Mol Psychiatry. 2016 Apr;21(4):450-63
pubmed: 26878891
Neuroimage. 2020 Oct 1;219:117018
pubmed: 32505698
Mol Psychiatry. 2006 Jul;11(7):622-32
pubmed: 16585942
Stereotact Funct Neurosurg. 1994;62(1-4):76-84
pubmed: 7631092
J Anxiety Disord. 2019 May;64:1-8
pubmed: 30852257
J Clin Psychopharmacol. 2001 Oct;21(5):488-92
pubmed: 11593074
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
J Neurosci. 2015 Jan 14;35(2):786-94
pubmed: 25589771
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Biol Psychiatry. 2019 May 1;85(9):726-734
pubmed: 30853111
Brain. 2020 Feb 1;143(2):684-700
pubmed: 32040561
Biol Psychiatry. 2010 Mar 15;67(6):535-42
pubmed: 20116047
Arch Gen Psychiatry. 2010 Oct;67(10):1061-8
pubmed: 20921122
Aust N Z J Psychiatry. 2018 Jul;52(7):699-708
pubmed: 28965430
JAMA Psychiatry. 2013 Jun;70(6):608-18; quiz 554
pubmed: 23740049
Nat Commun. 2020 Jul 3;11(1):3364
pubmed: 32620886
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Biol Psychiatry. 2005 Mar 1;57(5):510-6
pubmed: 15737666
Brain. 2020 Jul 1;143(7):2235-2254
pubmed: 32568370
Brain Stimul. 2014 Sep-Oct;7(5):727-31
pubmed: 25088461
Front Neurosci. 2012 Dec 05;6:171
pubmed: 23227001
Mol Psychiatry. 2018 Apr;23(4):843-849
pubmed: 28397839
Neurosurgery. 2003 Jun;52(6):1263-72; discussion 1272-4
pubmed: 12762871
Psychol Med. 2013 May;43(5):1081-91
pubmed: 22935427
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
Neuroimage. 2020 Nov 1;221:117180
pubmed: 32702488
World Neurosurg. 2018 Jun;114:e1079-e1085
pubmed: 29605702
Neuroimage. 2014 Nov 1;101:494-512
pubmed: 24784800
Neuroimage. 2018 Apr 15;170:132-150
pubmed: 27765611
Biol Psychiatry. 2018 Jul 1;84(1):28-37
pubmed: 29274805
Neuropsychopharmacology. 2006 Nov;31(11):2384-93
pubmed: 16855529
Brain Stimul. 2019 Nov - Dec;12(6):1345-1348
pubmed: 31353286
Brain. 2016 Apr;139(Pt 4):1200-10
pubmed: 26921616
N Engl J Med. 2008 Nov 13;359(20):2121-34
pubmed: 19005196
J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):103-12
pubmed: 7711480
Biol Psychiatry. 2019 May 1;85(9):706-707
pubmed: 30999984
Neuroimage. 2015 Feb 15;107:127-135
pubmed: 25498389
Biol Psychiatry. 2011 May 1;69(9):867-74
pubmed: 21272861
Neuroimage. 2019 Jan 1;184:293-316
pubmed: 30179717
Neuropsychopharmacology. 2010 Feb;35(3):686-91
pubmed: 19890260

Auteurs

Philip E Mosley (PE)

Systems Neuroscience Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. philip.mosley@qimrberghofer.edu.au.
Neurosciences Queensland, St Andrew's War Memorial Hospital, Spring Hill, QLD, Australia. philip.mosley@qimrberghofer.edu.au.
Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia. philip.mosley@qimrberghofer.edu.au.
Faculty of Medicine, University of Queensland, Herston, QLD, Australia. philip.mosley@qimrberghofer.edu.au.

François Windels (F)

Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.

John Morris (J)

Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.

Terry Coyne (T)

Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.
Brizbrain and Spine, the Wesley Hospital, Auchenflower, QLD, Australia.

Rodney Marsh (R)

Neurosciences Queensland, St Andrew's War Memorial Hospital, Spring Hill, QLD, Australia.
Faculty of Medicine, University of Queensland, Herston, QLD, Australia.

Andrea Giorni (A)

Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.

Adith Mohan (A)

Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, NSW, Australia.

Perminder Sachdev (P)

Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, NSW, Australia.

Emily O'Leary (E)

The OCD Clinic, Bulimba, QLD, Australia.

Mark Boschen (M)

School of Applied Psychology, Griffith University, Gold Coast, QLD, Australia.

Pankaj Sah (P)

Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.
Joint Center for Neuroscience and Neural Engineering, and Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong Province, P. R. China.

Peter A Silburn (PA)

Neurosciences Queensland, St Andrew's War Memorial Hospital, Spring Hill, QLD, Australia.
Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH